NEWSROOM

Get the latest Terumo Aortic news featuring our tailored thoracic,
thoracoabdominal and abdominal devices.

Terumo Aortic announces first commercial implant of the Thoraflex Hybrid device in the USA

Following the recent approval by the US Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment of patients with complex aortic arch disease, Terumo Aortic has now announced the first commercial implant of the device in the United States. Thoraflex Hybrid is a single use medical device

ATRIUM OPENING SIGNALS AMBITION

This week we cut the ribbon to open our spectacular new atrium reception space in our Renfrewshire facility, Scotland. The opening ceremony, performed by CEO Erik Pomp and Brian Coll, the longest serving member of the Terumo Aortic family with over 37 years’ service, marks a major milestone in our investment project which will see

TERUMO AORTIC ANNOUNCES ENROLMENT OF PATIENTS IN AN ALL-COMERS TREO AAA STUDY

Terumo Aortic announced today the enrolment of patients in an all-comers Abdominal Aortic Aneurysm (AAA) Study of the TREO Abdominal Stent-Graft System in the United States. The TREO Abdominal Stent-Graft System is approved by the US Food and Drug Administration (FDA) to treat patients with abdominal aortic aneurysms. This is a prospective, multi-center, non-randomised, single-arm,


1 2 7 8

For more updates on Terumo Aortic, follow us on Twitter or LinkedIn.

MEDIA ENQUIRIES

Please reach out to our media relations contact for
press enquiries about our innovative solutions.


Carrie White
Head, Global Marketing Communications
+44 (0) 141 812 5555